Company Filing History:
2 out of 2 
1 out of 3 Years Active: 2011-2018
Title: The Innovative Mind of Karl Lohner
Introduction: Karl Lohner, a prominent inventor based in Graz, Austria, has made significant contributions to the field of biochemistry. With three patents to his name, Lohner is recognized for his innovative work, particularly in the development of peptides aimed at treating cancer. His research demonstrates a deep understanding of peptide structure and functionality, which has the potential to impact cancer treatment profoundly.
Latest Patents: Lohner's latest patents focus on isolated peptides that consist of 12 to 50 amino acid residues. These peptides aim to utilize unique structures, such as beta-strands and alpha-helices, to effectively target cancer cells. Notably, the peptides exhibit a net positive charge of +7 or more and are characterized by their hydrophobic properties, which are crucial for their therapeutic functions. His advancements in this area signify important strides towards developing more targeted cancer therapies.
Career Highlights: Throughout his career, Lohner has collaborated with several prestigious organizations. His tenure at Newfield Therapeutics Corporation and the Austrian Academy of Sciences has provided him with a platform to innovate and conduct crucial research in the biomedical field. Lohner's work showcases his commitment to advancing medical science and improving patient outcomes through his inventions.
Collaborations: Lohner has had the privilege of collaborating with esteemed colleagues like Dagmar Zweytick and Sabrina Riedl. These partnerships highlight the collaborative nature of scientific research, as they work together to enhance the potential applications of their findings in real-world settings.
Conclusion: Karl Lohner's inventive spirit and dedication to cancer research position him as a key player in the scientific community. His patents reflect not only his expertise but also a commitment to developing innovative solutions that could benefit countless lives. As the field of biochemistry continues to evolve, Lohner's contributions will undoubtedly pave the way for future advancements in cancer treatment.